Giuseppe Ciaramella, President at Beam Therapeutics Inc. (BEAM), sold 102,220 shares at $26.36 ($2.7M) on 2024-11-06, disclosed to the SEC on 2024-11-08.
Scheduled sale ($2.7M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.36 | 51,110 | $1.3M | 50.0% |
| 2 | $26.36 | 51,110 | $1.3M | 50.0% |
| Total | $26.36 avg | 102,220 | $2.7M | 100% |
| Filing → |
| BEAM | SELL | 2025-04-03 | $273K | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-04-03 | $291K | — | Filing → |